Combined general meeting of may 16, 2024

ChÂtillon, france, april 25, 2024 combined general meeting of may 16, 2024 procedures for obtaining information and preparatory documents for the combined general meeting dbv technologies (euronext: dbv – isin: fr0010417345 – nasdaq stock market: dbvt), a clinical-stage biopharmaceutical company focused on treatment options for food allergies and other immunologic conditions with significant unmet medical need (the “company”), will hold its combined general meeting (the “general meeting”) on may 16, 2024, at 10:00 a.m. cet at the company's new headquarters located at iro building, 107 avenue de la rÉpublique, 92320 chÂtillon, france.
DBVT Ratings Summary
DBVT Quant Ranking